Tag Archives: Dr Angelos Stergiou

Angelos Stergiou Notes Benefits of Galinpepimut-S Following Autotransplantation

SELLAS Life Sciences Group’s Phase II clinical trials of galinpepimut-S, an immunotherapeutic anti-cancer treatment, have illustrated significant benefits for those patients who have utilized it following autotransplantation with high-risk multiple myeloma, particularly those with an adverse cytogenetic profile.  “We are … Continue reading

Posted in Angelos Stergiou | Tagged , , | Leave a comment

Angelos Stergiou Thrilled With Phase II Trial Results

Dr. Angelos Stergiou values SELLAS’ appointment of Dr. Jonathan Eckard to its executive team in light of Eckard’s experience as Director and Senior Biotechnology Analyst for Barclays, a universal bank with operations in over 50 countries and territories and 48 … Continue reading

Posted in Angelos Stergiou | Tagged , , , | Leave a comment

Angelos Stergiou Announces Dr. Jonathan Eckard Appointment

SELLAS Life Sciences Group specializes in biopharmaceuticals for late stage cancer immunotherapies which cover a significant range of indication for cancer.  SELLAS recently appointed Dr. Jonathan Eckard to their team as a Chief Business and Strategy Officer.  Dr. Eckard has … Continue reading

Posted in Angelos Stergiou | Tagged , , , | Leave a comment

Dr. Angelos M. Stergiou: The SELLAS Life Sciences Group Team

Dr. Angelos M. Stergiou, MD is the Founder, Chief Executive Officer (CEO) and Vice Chairman of the SELLAS Life Sciences Group. Dr. Angelos Stergiou founded SELLAS Life Sciences with his friend and colleague, Dr. Miltos K. Sugiultzoglu, MD and, through … Continue reading

Posted in Angelos Stergiou | Tagged , | Leave a comment

Dr. Angelos M. Stergiou, MD, ScD h.c.: Shape the World with a Biotechnology Career

Dr. Angelos M. Stergiou, MD, ScD h.c. has always wanted to change the world and give back to humanity. Through SELLAS Life Sciences Group, he is doing just that. SELLAS Life Sciences Group is a biopharmaceutical company that is behind … Continue reading

Posted in Angelos Stergiou | Tagged , | Leave a comment

Dr. Angelos Stergiou, MD, ScD h.c.: The WT1 Program

Dr. Angelos M. Stergiou, MD, is Founder, Vice Chairman and Chief Executive Officer of SELLAS Life Sciences Group, a biopharmaceutical company that is pioneering the cancer vaccination field. The one that’s receiving the most attention is the WT1 cancer vaccine, … Continue reading

Posted in Angelos Stergiou | Tagged , | Leave a comment

Dr. Angelos M. Stergiou, MD, ScD h.c.: Active Association Member

Dr. Angelos M. Stergiou, MD is the Vice Chairman of SELLAS Life Sciences Group and an active member of the American Academy of Physicians in Research, the World Medical Association, the Association of Clinical Research Professionals and is also a … Continue reading

Posted in Angelos Stergiou | Tagged , | Leave a comment